Alere Inc  

(Public, NYSE:ALR)   Watch this stock  
Find more results for ALR
0.00 (0.00%)
After Hours: 51.00 +0.01 (0.02%)
Oct 2, 4:11PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 34.41 - 51.00
Open     -
Vol / Avg. 0.00/2.27M
Mkt cap 4.47B
P/E     -
Div/yield     -
EPS -3.11
Shares 87.58M
Beta 0.21
Inst. own 95%

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin -16.86% -7.90%
Operating margin -5.20% 0.62%
EBITD margin - 14.07%
Return on average assets -6.72% -3.25%
Return on average equity -33.39% -11.93%
Employees 9,700 -
CDP Score - -


51 Sawyer Rd Ste 200
WALTHAM, MA 02453-3448
United States - Map
+1-781-6473900 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Alere Inc. is a provider of health information through diagnostic tests. The Company's segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The consumer diagnostics segment consists primarily of manufacturing operations related to its role as the exclusive manufacturer of products for SPD Swiss Precision Diagnostics (SPD), its joint venture with The Procter & Gamble Company (P&G). The Company's professional diagnostic solutions allow patients and their healthcare providers to work together to manage patients' conditions over the continuum of care, from the hospital to home. The Company offers lines of drugs-of-abuse tests, reagent systems and laboratory testing options.